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Cytotoxic  T cells  generated in the course of  viral  infection  of  mice show two types of 
specificity.  Cytotoxic  T cells  specific  to  one  virus  group  will  not  lyse  target  cells  infected 
with  unrelated  viruses  (1).  Furthermore,  for  lytic  interactions  to  occur,  the  virus-infected 
targets  must either  share the  H-2K  ~  and/or  H-2D region  of  the  major  histocompatibility 
complex  with  the  cytotoxic  T cells  (1)  or,  in  the  case  of  radiation  chimeras (2),  must  share 
H-2K or H-2D products with the chimeric environment in which the T  cells  were 
sensitized.  In  a previous  report  2  we  demonstrated  a further  level  of  specificity  of  cytotoxic 
T cells,  that is, the presence of  two distinct  subpopulations of cytotoxic  T cells  in the 
primary  and secondary response  to  type  A influenza  viruses  of  the  A (H0/N1)  and  A (H2/ 
N2) subtype.  One subpopulation is  specific  for  the  immunizing  virus.  The  other  subpepu- 
lation  exhibits  a high degree of cross-reactivity  between virus  subtypes. This report 
investigates  the possibility  that distinct  viral  antigens,  expressed on the surface  of  the 
infected  cell,  are recognized by the two different  subpopulations of influenza-specific 
cytotoxic  T cells.  Since influenza  viruses  of  the A (H0/N1)  and A (H2/N2)  subtypes have 
serologically  distinct  hemagglutinin and neuraminidase antigens,  one or both of  these 
virion  surface  glycoprotein  antigens could  serve  as  the  target  of  the  virus  strain-specific 
cytotoxic  T cells,  but these antigens are less  likely  candidates for  recognition  by cross- 
reactive  T cells.  All type A  influenza viruses do, however, possess two serologically 
crossreacting  nonglycosylated antigens-the matrix (M) protein  and ribonucleoprotein 
complex (RNP), both of  which are internally  located  in  the virion  (3).  Evidence to  date 
also  suggests  that  these  antigens are  not  present  on  the  surface  of  the influenza-infected 
cells  (3). 
* Recipient of a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical 
Research. 
1 Abbreviations  used in this paper:  2-DG, 2-Deoxy-D-Glucose; EID, egg infectivity dose; FCS, 
fetal calf serum; H, influenza virus hemagglutinin antigen; H-2, mouse major histocompatibility 
complex; M, influenza virus matrix protein antigen; N, influenza virus neuraminidase  antigen; 
RNP, influenza virus ribonucleoprotein antigen complex; T cell, thymus-derived lymphocyte. 
2 Braciale, T. J. 1977. Immunologic recognition of influenza virus-infected cells. I. Generation 
of a virus strain-specific and a cross-reactive subpopulation of cytotoxic T cells in the response to 
type A influenza viruses of different subtypes. Cell Immunol.  In press. 
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In this paper data are presented which demonstrate that influenza A matrix protein, 
but not RNP, is present on the surface of  target cells infected with a variety of  influenza A 
viruses of different subtypes.  Furthermore,  inhibition of glycoprotein synthesis in  in- 
fected target cells with 2-Deoxy-v-Glucose (2-DG) abrogates reactivity of infected target 
cells  to  lysis  by  virus  strain-specific,  but  not  cross-reactive cytotoxic T  cells.  These 
findings support the possibility that the influenza glycoproteins (hemagglutinin and]or 
neuraminidase) and matrix protein are the targets for the virus strain-specific and cross- 
reactive cytotoxic T cells, respectively. 
Materials and Methods 
General.  Male BALB/c mice (7-12 wk of age) were used throughout. P815 mastocytema cells, 
maintained in tissue culture, were used as target cells in all experiments. Dulbecco's Modified 
Eagle's Minimal Essential Medium (GIBCO, Grand Island, N. Y. Catalogue no. H-16) was used as 
medium in all cytotoxicity assays.  Grade III 2-DG was obtained from Sigma Chemical Co.,  St. 
Louis, Mo. Details on the immunization of mice with influenza virus, generation of secondary 
influenza-specific cytotoxic cells in vitro, and 5~Cr release assay have been presented in a previous 
report. 2 
Viruses.  Influenza virus strains A/WSN (H0/N1),  A/PR/8 (H0/N1), A/JAP (H2/N2),  A/Ann 
Arbor  (H2/N2),  A/Port Chalmers  (H3/N2),  and  a  high  growing recombinant  between A/Port 
Chalmers and A/PR/8- A/Port Chalmers-PR/8 (H3/N2)- were grown in embryonatsd eggs and 
stored as described previously.  ~ 
Antisera.  Rabbit  antisera  to  influenza  type  A  matrix  protein,  type  A  ribonucleoprotein 
complex, and subtype H2 hemagglutinin were kindly provided by Dr. W. G. Laver. The purified 
viral  antigens  were  obtained  from  egg-grown influenza  viruses  and  prepared  as  previously 
described (4). Isolated matrix protein, ribonucleoprotein, and hemagglutinin were obtained from 
virus strains A/Port Chalmers-PR/8 (H3/N2) (a high growing recombinant strain), A/Berk (H2/ 
N2), and A/JAP (H2/N2), respectively. Rabbits were immunized in both foot pads and intramuscu- 
larly in the thighs with isolated antigen in a 50% suspension of Freund's complete adjuvant. On 
the 40th  day the animals received a second intramuscular dose of antigen in Freund's complete 
adjuvant. The animals were bled 7-9 days later. Sera were separated and stored at -20°C. The 
sera were judged to be specific by standard serologic criteria. Antisera to the matrix protein and 
RNP  reacted  exclusively with  their  respective antigens  in  immunodiffusion and  showed  no 
activity in the hemagglutination inhibition test; similarly, the anti-hemagglutinin antiserum 
demonstrated a high titer (> 1/1,000) in the hemagglutination inhibition test with homologous H2/ 
N2 virus (A/JAP) but showed no specific activity against type A virus of different subtypes or type 
B virus. This antiserum was also unreactive in immunodiffusion with purified internal virion 
antigens. Day 0 bleeds from the respective immune serum donors served as preimmune sera in the 
cytotoxicity assay. All sera were heat-inactivated at 56°C for 30 rain before use. 
Assay for Antibody Plus Complement-Mediated Cytotoxicity.  P815  cells were labeled with Na 
s~Cr O4 at a concentration of  50-150 ~Ci/106 viable cells for 1 h at 37°C in serum-free medium. After 
washing, the cells were resuspended in serum-free medium and samples of 1-4  ×  10  e cells in 0.5 
ml vol were infected in suspension with  10 egg infectivity doses  (EID)~ of virus (as infectious 
aUantoic fluid) per cell. The cells were incubated at 37°C for 30 rain to allow virus adsorption then 
washed and resuspended  in medium supplemented with  10% heat-inactivated fetal calf serum 
(FCS). The cells were maintained in suspension for 6.5 h at 37°C in a humid atmosphere of 10% 
CO2, 7%  O2,  and  83%  N2  to  allow viral antigen expression.  The cells were then pelleted and 
resuspended in fresh medium plus 10% FCS at a concentration of 4 × 10  ~  cella/ml. 0.05-ml samples 
of cells (containing 2 x 104 cells) were distributed into individual wells of 96 well (6 mm diameter) 
plastic tissue culture trays (Linbro Chemical Co., New Haven, Conn.).  Serial twofold dilutions of 
immune or preimmune serum in medium plus 10% heat-inactivated FCS were added to the wells 
in 0.05 ml vol. The trays were incubated at room temperature (18-22°C) for 45-60 rain before the 
addition of complement (0.1 ml of a 1:5 dilution of guinea pig serum per well). The trays were then 
incubated at  37°C  for  3  h in  a humid atmosphere  of  10% COs, 7% 02,  and  83% Ns.  After  incubation, 
0.1  ml  of  supernate  was  removed from  each  well  an  the  7-emissions  in  the  supernate  were  counted 
in  a Packard  Auto-Gamma Spectrometer, Packard  Instrument  Co.,  Inc.,  Downers Grove,  Ill.  Total 
releasable  radioactivity  from the targets  (water lysis)  was obtained by adding 0.05  ml of  labeled T.  J.  BRACIALE  675 
target cells (2 x  104 cells) to 20 vol of distilled water, incubating the cells at 37°C in parallel with 
the assay and determining the number of counts in one-half of the lysate supernate. Target cells 
were also incubated either with medium alone, with medium pins immune serum, or with medium 
plus complement. The highest sxCr release from these three controls was taken as spontaneous 
5~Cr release.  This value usually ranged from 5 to  12% and was always less than 15%.  Percent 
specific 5~Cr release was obtained from the formula: 
Test counts -  spontaneous release  x  100 
Water lysis counts -  spontaneous release 
All values are the mean percent specific slCr release of four replicate wells. The standard errors of 
the means were always less than -+3% and are omitted from the figures for clarity. 
Experiments with the inhibitor of glycopretein synthesis 2-DG were carried out essentially as 
described above. After the 30-min period of virus absorption the suspensions of infected P815 cells 
were divided into two equal portions. One portion of cells was transferred into medium plus 10% 
FCS containing 2-DG at a  concentration of 5 mM. The other portion of cells was maintained in 
medium plus 10% FCS alone. Both samples were incubated for 6.5 h at 37°C and assayed in parallel 
as  described  above.  Cells  infected  in  the  presence  of 2-DG  were  assayed  for  antibody  plus 
complement-mediated lysis in the presence of 5  mM  2-DG,  i.e.  both the dilutions of sera and 
complement contained 2-DG at a  concentration of 5 mM. 2-DG appeared to have no effect on the 
rate of spontaneous 5xCr release from infected P815 cells as these values were comparable beth 
with and without 2-DG. 
Complement.  Fresh frozen guinea pig serum served as the complement source. The serum was 
adsorbed with agarose  (80 mg/ml of serum) just before use. A  one to five dilution of serum in 
medium plus 10% heat-inactivated FCS was used in the assay.  The complement source was not 
cytotoxic for P815 cells as judged by 5~Cr release from target cells in the presence of complement 
alone. 
Assay for Cell-Mediated Cytotoxicity.  The cytotoxicity assay with unlabeled infected competi- 
tor cells was carried out as described in a previous report. 2 Cytotoxicity assays were carried out in 
parallel in the presence and absence of 5 mM 2-DG. 5xCr-labeled P815 cells were infected with 10 
EIDso doses of influenza virus per cell. After a  30-min incubation at 37°C,  the cells were washed 
and divided into two equal portions. One portion of cells was transferred into cold (4°C) medium 
plus  10%  FCS  containing 2-DG  at  a  concentration of 10  mM.  The other portion of cells was 
transferred into medium plus 10% FCS without 2-DG. The final cell concentration in each case was 
2 x  105 cells/ml. The cells were immediately dispersed into wells of the assay trays (2  x  104 cells/ 
well in 0.1 ml vol) as described, s Mixtures of secondary infiuenza-immune cytotoxic effector cells 
generated in vitro  2 and unlabeled infected competitor cells were then added to the wells in a 0.1-ml 
vol of medium plus 10% FCS without 2-DG. The final concentration of 2-DG in wells containing 2- 
DG was 5 mM. The assay trays were incubated at 37°C for 6.5 h  and percent specific 5~Cr release 
from the assay wells was determined as described, z Since 2-DG was expected to inhibit glycopro- 
tein synthesis in both the 51Cr-labeled targets and unlabeled competitor cells, the competitor cells 
were infected 6.5 h before the labeled targets and maintained in suspension at 37°C for this time 
period.  This procedure allowed expression of viral antigens by the competitor cells before they 
were added to assay wells containing 2-DG. 
Results 
Lysis  of Influenza  Virus-Infected P815 Cells by Anti-Matrix Antibody  and 
Complement.  To  determine  if either  or both  internal  virion  antigens  (matrix 
protein  and  RNP)  are  expressed  on  the  surface  of infected  cells,  slCr-labeled 
P815  cells were  infected  with  A/WSN  (H0/N1),  A/JAP  (H2/N2),  or B/Lee  virus 
and  tested  along  with  uninfected  cells  in  the  51Cr  release  assay  for  their 
susceptibility  to complement-dependent  lysis  by  antisera  specific for influenza 
A-matrix  protein,  RNP,  or hemagglutinin  of the  H2 subtype.  The  latter  antise- 
rum  was  included  as a  specificity  control  since  the  hemagglutinin  antigen  has 
been  demonstrated  on the  surface  of influenza-infected  cells by several  different Anti A RNP  Anti HA (H2-JAP) 
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FIG.  1.  Cytotoxicity of specific anti-influenza antisera for influenza-infected  P815 cells. 
P815 cells were infected with the indicated  influenza  strains (A/WSN, A/JAP, B/Lee) and 
tested along with uninfected  P815 cells for complement-dependent  lysis in the presence of 
rabbit antiserum to influenza A matrix protein (Panel A), to influenza A ribonucleoprotein 
(Panel  B) or to influenza  subtype H2 hemagglutinin  (Panel  C).  Closed circles  (@---0) 
represent the lytic activity of the various immune sera. Open circles (O--O) represent the 
lytic activity of preimmune serum from the same donor. Details in Materials and Methods. 
techniques  (5-7).  Hyperimmune rabbit antiserum  to purified influenza  A-ma- 
trix  protein  antigen  in  the  presence  of  complement  specifically  lyses  cells 
infected with A/WSN  (H0/N1)  and A/JAP  (H2/N2) but not uninfected  cells or 
influenza  B/Lee-infected cells  (Fig.  1 A).  On the other hand,  antiserum to the 
RNP antigen shows no significant lysis on any cell above the background seen 
with pre-immune serum (Fig.  1 B). Furthermore,  antiserum to the H2 (A/JAP) 
hemagglutinin specifically lyses only with A/JAP (H2/N2) infected cells. These 
findings indicate that both influenza A-matrix protein and viral hemagglutinin 
are expressed on the surface of infected P815 cells during the course of infection T.  J.  BRACIALE  677 
at  a  time  (6.5  h)  when  these  targets  are  susceptible to  lysis by cytotoxic T 
lymphocytes.  2 
Although matrix protein could be detected on surfaces of both AJWSN and A/ 
JAP-infected  cells,  the  cytotoxic  potency  of the  anti-matrix  antiserum  was 
greater  for  the  former  strain  (dilution  end  point  =  1/5,120;  maximum  51Cr 
release  =  70%) than for the latter  (dilution end point  =  1/320;  maximum ~lCr 
release  =  30%).  To assess whether this difference in susceptibility to lysis was 
unique  to  these  two  viruses  or  perhaps  reflected  differences  between  virus 
subtypes, target  cells infected with  several  other type A  viruses  of different 
subtypes were examined  in the 5~Cr release assay with anti-matrix  antibody. 
The virus strains tested were: A/PR/8 (H0/N1), A/Ann Arbor (H2/N2), and A/ 
Port Chalmers (H3N2). A fourth strain, A/Port Chalmers-PR/6 (H3/N2) -  a high 
growing recombinant virus between Port Chalmers and PR/8 which contains the 
virion surface antigens of the Port Chalmers strain-was also included since the 
anti-matrix  antiserum was produced against the matrix protein of this strain. 
As Fig. 2 shows, infected targets of all three subtypes are specifically lysed by 
anti-matrix  antibody  and  complement  but  to  different  degrees.  Target  cells 
infected with the H0/N1 virus, PR/8, were most susceptible to lysis, while Ann 
Arbor  (H2/N2)-infected  targets  were  least  susceptible.  These  results  taken 
together with the data in Fig. 1 A suggest that target cells infected with type A 
influenza virus of different subtypes differ in their susceptibility to lysis by anti- 
matrix  antibody and complement.  In this connection,  it is worthwhile noting 
that  target  cells infected with the A/Port  Chalmers-PR/8  recombinant  which 
probably contains the A/PR/8 matrix protein (W. G. Laver, personal communi- 
cation) appear to be as susceptible to lysis as targets infected with A/PR/8 or A/ 
WSN (Figs. 1 A and 2). Two explanations for this phenomenon seem most likely: 
(a) type A  influenza viruses of different subtypes differ in the kinetics and/or 
degree of expression of M protein on the cell surface; (b) matrix protein antigens 
of different subtypes cross-react to different degrees with a  given antiserum. 
Experiments now in progress may distinguish between these two possibilities. 
Grant et al. (8) have reported that oncornavirus antigen passively adsorbed to 
cell surfaces can render these cells susceptible to lysis by specific antibody and 
complement. This finding raises the possibility that matrix protein may also be 
passively adsorbed to the surface of infected cells. To test this possibility, cell 
mixing experiments were performed in which unlabeled A/WSN infected cells 
were added immediately after infection to 51Cr-labeled uninfected or B/Lee-in- 
fected P815 cells. The cell mixtures were then incubated for 6.5 h to allow viral 
antigen expression and tested for their susceptibility to lysis by anti-A matrix 
protein antibody and complement in the 51Cr release assay.  No lysis of unin- 
fected or B/Lee-infected cells could be detected above that seen in Fig. 1 A with 
the addition of up to a  10-fold excess unlabeled A/WSN-infected cells. Further- 
more,  at 6.5 h  into infection,  medium release  (release of 5~Cr from cells incu- 
bated in medium  without  antibody and  complement)  from both infected and 
uninfected cells was equivalent (5-12%). Also, both infected and uninfected cells 
showed greater than 95% viability as measured by trypan blue exclusion. Hence 
there is no evidence for death or damage of infected cells at the time of assay as 
judged  by  these  criteria.  These  results,  while  not  formally  ruling  out  the 678  T-CELL  RECOGNITION  OF  SPECIFIC  INFLUENZA  ANTIGENS 
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FIG. 2.  Cytotoxicity of  anti-A matrix protein antisera for P815 cells  infected with type A 
influenza viruses of  different  subtypes. Symbols as in Fig. 1. Details in text. 
possibility of adsorption of matrix protein to the cell surface, do suggest that 
under the conditions described here, passively adsorbed matrix protein, released 
from damaged cells, is not a major contributor to the matrix protein detectable 
on the infected cell surface. 
In the above experiments, varying degrees of nonspecific lysis were observed 
with preimmune sera (Figs. 1 and 2). This nonspecific activity was not observed T.  J.  BRACIALE  679 
on uninfected target cells  and could not be adsorbed out with uninfected cells. 
The degree of nonspecific lysis  obtained with any immune  serum-preimmune 
serum pair appeared to depend on the infecting  virus strain.  A/WSN  and A/PR/ 
8-infected  cells  showed the highest degree of  nonspecific  lysis  and A/JAP and B/ 
Lee the lowest. This phenomenon  either could be due to some alteration in the 
cytoplasmic membrane as a result  of  virus infection  which renders the cell  more 
susceptible to nonspecific lysis  or, as has been shown in herpes virus-infected 
cells  (9),  could be due to the expression of  immunoglobulin  receptors on the cell 
surface after virus infection which could facilitate  nonspecific adsorption  of 
immunoglobulin  to the cell  surface. 
Effect of 2-DG on the Susceptibility  of Influenza-Infected  P815 Cells to Lysis 
by Cytotoxic  T Lymphocytes  and Antibody.  The above experiments demon- 
strate that influenza matrix protein which is an internal antigen in the virion is 
expressed on the surface of P815 cells infected with type A influenza virus of 
different subtypes.  Since the matrix protein antigens of all type A influenza 
viruses are serologically related, this antigen could be recognized by the subpop- 
ulation of cytotoxic T cells which cross-reacts between subtypes. On the other 
hand,  virus strain-specific cytotoxic T  cells may recognize the viral antigens 
specific for an influenza A subtype (hemagglutinin and/or neuraminidase). One 
test of this possibility is to inhibit the expression of particular viral antigens on 
the target cell surface and to test the susceptibility of the target cells to lysis by 
either strain-specific or cross-reactive cytotoxic T cells. 
Influenza hemagglutinin and neuraminidase are glycoproteins (10, 11) and 
their formation is therefore susceptible to inhibitors of glycoprotein synthesis. 
Influenza matrix protein is nonglycosylated (3) and its formation should not be 
susceptible to these inhibitors. The glucose analogue 2-DG has been shown to 
inhibit the synthesis (12, 13) and glycosylation (14, 15) of the influenza glycopro- 
teins in influenza-infected cells. Furthermore, Jackson et al. (16) have recently 
shown that 2-DG significantly inhibits (80-90%) glycoprotein synthesis in P815 
cells while inhibiting total protein synthesis to a lesser extent (30-40%). 
To directly determine the effect of 2-DG on the expression of viral antigens at 
the cell surface, virus-infected cells, treated with 2-DG, were tested for their 
susceptibility to lysis by anti-hemagglutinin or anti-matrix antibody and com- 
plement. 51Cr-labeled P815 cells were infected with influenza virus and after the 
period  of virus  adsorption  (30  min)  were transferred into  medium with  or 
without 5 mM 2-DG.  3 The cells were incubated at 37°C for 6.5 h to allow viral 
antigen expression. At that time s~Cr release was measured in the presence of 
specific antibody and complement. A/WSN-infected cells in the presence of 2-DG 
are susceptible to lysis by anti-matrix antibody and complement (Fig. 3). On the 
other hand,  AJJAP-infected are rendered almost completely insusceptible to 
lysis by antiserum to the A/JAP hemagglutinin when maintained in 2-DG (Fig. 
4). While these findings are in agreement  with the predicted effect of 2-DG, (Fig. 
3 also shows that 2-DG does somewhat decrease in the susceptibility of A/WSN- 
infected cells to lysis by anti-matrix antibody. This effect is also seen with AJ 
JAP and A/PR/8-infected cells, and probably reflects an inhibitory effect  of 2-DG 
3  The 2-DG concentration  of  5  mM was chosen  on the  basis  of  data  of  Jackson  et  al. (17). 680  T-CELL  RECOGNITION  OF  SPECIFIC  INFLUENZA  ANTIGENS 
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Fz~.  3.  Effect of 2-DG on the complement-dependent ]ysis of influenza A/WSN-infected 
P815 cells by anti-A matrix protein antiserum. Symbols as in Fig. 1. Details in Materials 
and Methods and text. 
on overall  protein  synthesis  (16).  Although  anti-hemagglutinin  antisera  spe- 
cific for other virus strains were not available, the inhibitory effect of 2-DG on 
viral hemagglutinin  expression could be assayed by another technique, that is, 
the capacity of virus-infected cells to specifically adsorb fowl erythrocytes (5). 
Up to 10 h after infection (a time when 90% or more cells can hemadsorb) P815 
cells infected with A/WSN, A/JAP, or A/PR/8 and maintained in 2-DG showed 
no hemadsorption  (data not shown). 
The  above results  provide  direct  evidence that  2-DG acts  preferentially  to 
inhibit the expression of influenza glycoprotein on the infected cell surface but 
not  matrix  protein  expression.  The  effect of 2-DG  on  lysis  of virus-infected 
targets by cytotoxic T  cells was then examined.  Spleen cells from mice previ- 
ously  immunized  with  A/JAP  virus  were  stimulated  in  vitro  with  A/JAP- 
infected stimulator cells. 2 After 5 days in culture, the cytotoxic activity of the 
cultured  spleen cells was analyzed by cold target  competition  on 51Cr-labeled 
homologous  (A/JAP-infected)  targets  or  target  cells  infected  with  influenza 
virus of a different subtype (i.e., A/WSN) in the presence or absence of 2-DG. As 
shown previously,  2 in the absence of 2-DG, the cytotoxic activity ofJAP effectors 
tested on homologous targets is inhibitable by JAP cold targets but not by WSN 
or influenza B/Lee cold targets (Fig. 5 A). In the presence of 2-DG, however, both 
A/JAP  and  A/WSN  cold targets  inhibit  killing  of A/JAP targets  by A/JAP 
effectors (Fig. 5 C). Furthermore,  inhibition by A/JAP and A/WSN cold targets T.  J.  BRACIALI¢  681 
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Effect of 2-DG on the complement-dependent lysis of influenza A/JAP-infected 
P815 cells  by antiserum to the A/JAP hemagglutinin. Symbols as in Fig. I. Details in 
Materials and Methods. 
of killing of 5'Cr-labeled heterologous (A/WSN) targets by JAP effectors is not 
altered by 2-DG treatment (Fig.  5 B  and D).  The most likely explanation for 
these data is that JAP-infected targets treated with 2-DG,  which lack viral 
glycoproteins, are not recognized by the virus strain-specific subpopulation of 
cytotoxic T cells but are lysed by the cross-reactive T-cell subpopulation.  Pre- 
sumably, these latter T cells recognize a  nonglycosylated viral antigen on the 
infected cell surface, such as M protein. 
Several features of the data in Fig.  5 suggest that other effects of 2-DG on 
cellular function, e.g., inhibition of glycolysis (17) are unlikely to be relevant. 
First, the overall lytic activity of cytotoxic T cells was not inhibited by 2-DG. 
Second, the susceptibility of 51Cr-labeled targets to lysis was unaltered in the 
presence of 2-DG.  Third,  the effect of cold competitors on killing of A/WSN 
targets by A/JAP effectors was unchanged in the presence of 2-DG (Fig. 5 B and 
D). 
Further evidence of the specificity of the 2-DG effect comes from experiments 
with cross-reactive cytotexic T  cells.  As demonstrated in a  previous report, 2 
stimulation of primed spleen cells with type A influenza of a different subtype 
results in specific enrichment of the cross-reactive T-cell subpopulation. When 682  T-CELL  RECOGNITION  OF  SPECIFIC  INFLUENZA  ANTIGENS 
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FIG.  5.  Effect  of 2-DG on  the inhibition of homologous  secondary cytotoxic  T  cells by 
unlabeled cold competitors.  Spleen cells from BALB/c mice previously  immunized with 
influenza A/JAP  (Respender) were cultured in vitro with stimulator cells infected with 
influenza A/JAP (Stimulator) as previously described. 2 After 5 days in culture, the spleen 
cells were tested for cytotoxicity on slCr-labeled infected P815 target cells in the presence of 
increasing numbers of unlabeled cold competitors. Cytotoxicity assays were carried out in 
parallel in the absence (-2-DG) or presence (+2-DG) of 5 mM 2-DG. The ratio ofeffectors to 
targets is 2.5:1 in assays carried out in the absence of 2-DG and 5:1 for assays in the presence 
of 5  mM  2-DG.  The  ratio  of unlabeled  competitors  to  labeled  targets  is  as  indicated. 
Unlabeled  competitors  are  P815  cells  infected  with  influenza  A/WSN  ([~--O),  A/JAP 
(LI--L~), B/Lee (O--Q) or uninfected (O--O). Values are the means of four individual assay 
wells.  Standard errors,  less than  _+ 3% in all cases,  are omitted for clarity.  Asterisk  (*) 
51  indicates the percent specific  Cr release in the absence of competitor cells. T.  J.  BRACIALE  683 
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Fro.  6.  Effect  of 2-DG on the inhibition  of heterologous secondary cytotoxic  T cells  by 
unlabeled cold  competitors. Spleen cells  from BALB/c mice previously immunized with 
influenza A/WSN  (Responder) were cultured in vitro  with stimulator cells  infected  with 
influenza A/JAP (Stimulator) and tested for cytotoxic  activity  after  five  days of  culture. 
Other information as in Fig. 5. 
A/WSN-primed spleen cells  stimulated in  vitro  with A/JAP-infected stimulator 
cells  are examined for lytic  activity  by cold  target  competition,  the pattern of 
competition by cold  targets  is  unaffected  by 2-DG (Fig.  6). 
Discussion 
Immunization of mice with type A influenza virus results in the generation of 
two populations of cytotoxic T cells,  one of which is specific for the target cells 
infected with the immunizing virus, the other of which cross-reacts with target 
cells infected with type A  influenza viruses of different subtypes (18). 2 In some 
cases,  influenza A  strains of different subtypes (e.g.  A  H0/N1,  A  H2/N2) have 
both serologic,  ally unrelated hemagglutinin and neuraminidase antigens.  Since 
these two virion surface antigens are also thought to be the only viral antigens 
expressed on the surface of the infected cell (3), the existence of a cross-reactive 
cytotoxic population was unexpected.  The purpose of this report was to deter- 684  T-CELL  RECOGNITION  OF  SPECIFIC  INFLUENZA  ANTIGENS 
mine if the reactivity patterns exhibited by these two cytotoxic T-cell popula- 
tions could be accounted for by known viral antigens. Experiments presented 
here indicate: (a) that influenza matrix protein which is an internal antigen in 
the virion appears to be expressed on the surface of P815 cells infected with type 
A influenza viruses; (b) that inhibition of viral glycoprotein expression but not 
matrix protein expression on the target cell surface by 2-DG renders infected 
cells unsusceptible to lysis by virus strain-specific cytotoxic T cells, but does not 
affect killing by cross-reactive cytotoxic T cells. 
Evidence for the internal location of influenza matrix protein has for the most 
part come from electron microscopic observations which demonstrate an elec- 
tron dense layer on the inner surface of the lipid bilayer of the virion and on the 
inner surface of the cytoplasmic membrane of the infected cell at virus budding 
sites (3, 19). The lack of reactivity of anti-matrix antibody with intact virions in 
standard serologic tests (20) as well as studies with subviral particles (21, 22) 
adds further support for the internal location of the matrix protein at least in 
the virion, although experiments with protease-treated virus particles suggest 
that the molecule may be embedded in the lipid bilayer of the virion (23). Data 
presented here, however, strongly suggest that influenza A  matrix protein is 
expressed during the course of infection on the surface of influenza-infected 
cells.  Rabbit  antiserum  prepared  against  purified  matrix  protein  from egg- 
grown virus specifically lysed, in the presence of complement, P815 target cells 
infected with  type A  influenza of three different subtypes,  but  did not  lyse 
influenza B/Lee-infected or uninfected targets. This pattern of cross-reactivity 
exhibited by the anti-matrix antiserum is consistent with the known serologic 
cross-reactivity of influenza A matrix protein from viruses of different subtypes 
(24). Nonspecific adsorption of matrix protein onto the surface of infected cells 
appears not to be an important factor in the observed lysis of infected cells by 
anti-matrix  antibody,  as  cell  mixing experiments failed to  demonstrate en- 
hanced cytotoxicity of 51Cr-labeled unrelated targets  (B/Lee-infected or unin- 
fected) in the presence of an excess unlabeled susceptible cells. It is also unlikely 
that the cytotoxic activity of the anti-matrix antisera is due to contaminating 
antibodies to other viral  antigens since among the major viral antigens only 
antibody to the RNP complex would be expected to show cytotoxicity for the 
targets infected with type A viruses of different subtypes. Antiserum directed to 
the RNP complex, however, was not specifically cytotoxic. Furthermore, the 
specificity of the assay as a  method of detecting viral antigens is supported by 
the fact that antiserum directed to the A/JAP (H2/N2) hemagglutinin is cyto- 
toxic only for A/JAP-infected targets. 
Although the experiments presented here have dealt exclusively with influ- 
enza-infected P815  cells,  Ada  and  Yap  4 have  recently shown  that  a  newly 
synthesized polypeptide with the molecular weight and electrophoretic proper- 
ties of matrix protein can be precipitated from the outer surface of influenza- 
infected L929 cells with purified anti-matrix antibody. Thus two different mu- 
rine cell lines both of which are susceptible to lysis by cross-reactive cytotoxic T 
cells when infected with type A influenza virus (18)  2 appear to express matrix 
protein on their cell surfaces. Finally, there is a precedent for the expression of 
4  Ada, G. L., and K. L. Yap. Manuscript in preparation. T. J. BRACIALE  685 
internal  virion  antigens on the cell  surface  in  the oncornavirus model where the 
virion  core  antigen p3o is detectable  on the surface  of  transformed cells  (8, 25, 
26). 
The infection of both P815 and L  cells with influenza virus appears to be 
abortive, that is, infectious virus particles are not produced by the infected cell. 
This fact raises the possibility that expression of matrix protein on the cell 
surface may be  a  feature of abortively infected cells,  but  not  productively 
infected cells. This possibility cannot be excluded from the data presented here. 
Experiments are now in progress to test this possibility. 
Experiments with the inhibitor of glycoprotein synthesis 2-DG directly impli- 
cated the influenza glycoprotein(s), hemagglutinin, and/or neuraminidase as 
the target of  the virus strain-specific cytotoxic  T-cell population, since inhibition 
of glycoprotein synthesis in the target cells renders the target insusceptible to 
lysis by this T-cell population. Evidence in favor of matrix protein at the target 
of the cross-reactive cytotoxic T-cell population is at present circumstantial, i.e. 
2-DG-treated target cells  express  matrix protein  on  their  surfaces and  are 
susceptible to  lysis by the cross-reactive T-cell population.  Support  for this 
concept comes also from the fact that among the influenza-specified  pelypeptides 
only H, N, and matrix protein can be detected in plasma membrane prepara- 
tions  of infected cells  (27). Furthermore, recent results in the  oncornavirus 
system suggest that cytotoxic T cells specifically recognize the internal virion 
antigen p3o on the surface of virus-transformed  target cells (28). Direct evidence 
for the role of matrix protein in cross-reactive killing by cytotoxic T cells may 
come from blocking experiments with anti-matrix antibody. Such experiments 
are now in progress. 
The phenomenon of  heterotypic  immunity, in  which prior  infection  with type 
A  influenza of one subtype increases resistance to challenge with virus of 
another subtype (29),  has not been adequately explained. In this connection 
Webster and Hinshaw have recently  demonstrated that parenteral immuniza- 
tion  of  mice with matrix protein  enhances the clearance  of  influenza  virus  from 
the lungs of  these  mice when subsequently challenged by intranasal  inoculation 
with infectious  virus,  s  Both of  these phenomena could be  explained on  the basis 
of findings reported here. If epithelial cells  of the respiratory tract, when 
infected with influenza virus express matrix protein  on their surfaces,  they 
would in theory be susceptible  to lysis  by cytotoxic  T cells  and/or antibody 
generated in  response to  matrix protein  either  from prior  infection  with virus  of 
a different  subtype or from prior  immunization with this  antigen. Of greatest 
interest  in this  regard is the possibility  of  influencing  the course of  influenza 
infection  in humans via the immune response to influenza  matrix protein. 
Two mechanisms have been proposed to explain the specific  recognition of 
virus-infected  cells  by cytotoxic  T cells  and the concomitant H-2 restriction  of 
this  recognition.  On one hand there is  the possibility  that  cytotoxic  T cells  have 
two independent classes  of  receptors  which recognize  H-2  K or  D  gene products 
and viral  antigens respectively  (dual  recognition)  (30-32).  In  this  instance  the  K 
or D  gene products and the viral  antigens can be considered to be discrete 
s Webster, R. G., and V. S. Hinshaw. 1977. Matrix protein from influenza A virus and its role in 
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independent entities on the surface of the infected cell. On the other hand, there 
is the possibility that cytotoxic T cells possess a single receptor with specificity 
for both viral and H-2-coded products on the cell surface. In this case, either 
viral  antigens and H-2  gene products must be  intimately associated on the 
infected cell surface forming a new interaction antigen (1) or viral antigens must 
be specifically altered by K  or D  gene products to be recognized as self (altered 
self) (33). The results presented in this and a previous report  2 suggest that the 
two subpepulations of cytotoxic T cells generated in response to influenza virus 
recognize different influenza virus  antigens  on the surface of virus-infected 
histocompatible cells. These results are compatible with the dual recognition 
model of cytotoxic T-cell recognition as outlined above. Furthermore, if, as the 
present  results  suggest,  influenza matrix  protein  and  one or both  of virion 
surface glycoproteins  (hemagglutinin and neuraminidase) are the targets  of 
different cytotoxic T-cell subpopulations, then the receptor on the T cell which 
recognizes viral antigens must have at least the same degree of specificity as 
anti-matrix  and  anti-hemagglutinin  (or  anti-neuraminidase)  antibody.  This 
conclusion is consistent with current evidence for sharing of idiotypes (immuno- 
globulin Vx regions?) between T  cells and antibody (34). Explanation of the 
present  results  by an altered self model for cytotoxic T-cell recognition has 
certain limitations.  It has  been proposed that  viral  antigens are specifically 
glycosylated by batteries of glycosyl transferase enzymes encoded in the K  or D 
regions of the H-2  locus  and that  the pattern  of carbohydrate on  the  viral 
antigens  dictate the H-2  specificity of cytotoxic T-cell recognition  (33).  The 
finding in this report that inhibition of glycoprotein synthesis in the target cell 
by 2-DG inhibits lysis of target cells by one subpopulation of cytotoxic T cells but 
not  the  other  argues  against  this  model.  Furthermore,  if influenza matrix 
protein which is a nonglycosylated protein at least in the influenza virion (3) is 
the target for the cross-reactive cytotoxic T  cells, then glycosylation of viral 
polypeptides  would  appear  to  be  irrelevant  to  cytotoxic T-cell  recognition. 
Recent studies with mice bearing mutations in the K  and D  regions of the H-2 
locus also argue against this model (35). 
Another model for altered self recognition is the formation of a new interac- 
tion antigen as a  result of association between viral antigens and H-2 K  or D 
products on the infected cell surface. Since influenza is a  clean virus, that is, 
host proteins are not incorporated into the virion, it is unlikely that the viral-H- 
2 association is covalent. However, it is possible that covalent association could 
occur in areas of the cell surface where virus budding is not occurring. Whether 
this association is covalent or noncovalent, the results presented here would 
imply that influenza antigens (i.e., the viral glycoproteins and matrix protein) 
with  different physical  and  chemical  properties  (3)  are  equally  capable  of 
associating with H-2 specified pelypeptides. 
The experiments presented here have dealt with the structures on the surface 
of virus-infected cells which are recognized by cytotoxic T cells. These experi- 
ments  suggest  that  distinct  influenza antigens  expressed  on  the  surface of 
infected cells  are  recognized independently by influenza-specific cytotoxic T 
cells. At issue still is the nature of  the recognition structure(s) on the cytotoxic T 
cell. While no definite conclusions can be drawn from the above results, influ- T.  J.  BRACIALE  687 
enza virus may prove to be a useful probe in the study of the receptor(s) on 
cytotoxic T cells. 
Summary 
Two distinct  subpopulations of  cytotoxic T cells  are generated in  the primary 
or secondary response of  mice to type A influenza viruses.  One subpopulation is 
specific  for  the immunizing virus strain.  The other subpopulation shows a high 
degree of  cross-reactivity  for heterologous type A  virus of  a different  subtype. 
This report examines  the possibility  that distinct influenza  virus antigens, 
expressed on the surface of the infected cell,  are recognized by the different 
subpopulations of  influenza-specific  cytotoxic  T cells.  Data are presented which 
demonstrate that influenza A  matrix protein, an internal virion antigen, is 
detectable on the surface of target cells  infected with influenza A  viruses of 
different subtypes. Since this  viral  antigen is type specific,  i.e.,  serologically 
cross-reactive  among all  type A influenza viruses,  it  could serve as  the target for 
cross-reactive cytotoxic T cells.  To further examine the specificity  of the two 
cytotoxic T-cell subpopulations,  experiments  were carried out by using the 
inhibitor of glycoprotein synthesis  -  2-Deoxy-D-Glucose  2-DG. These experi- 
ments examine first  the effect  of 2-DG on the expression of influenza matrix 
protein and viral glycoprotein  on the infected cell surface and second, the 
susceptibility of 2-DG-treated target cells  to lysis  by cytotoxic T  cells.  2-DG 
inhibits the expression of the viral hemagglutinin  glycoprotein  on the cell 
surface but does not inhibit the expression of  the nonglycosylated matrix pro- 
rein. Furthermore, inhibition of  glycoprotein synthesis in infected target cells 
abrogates the reactivity  of  infected target cells  to lysis  by virus strain-specific 
but  not  cross-reactive  cytotoxic  T cells.  These findings suggest that  the  influenza 
glycoproteins (hemagglutinin and/or neuraminidase) and the nonglycosylated 
matrix protein are the targets for the virus strain-specific  and cross-reactive 
cytotoxic  T cells,  respectively.  These results  are discussed in  the light  of  availa- 
ble information on influenza virus structure and the biology of  influenza infec- 
tion and in terms of current models for cytotoxic T-cell recognition of virus- 
infected cells. 
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